← All trials
NCT02342171
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 28, 2015
- Primary completion
- Jul 31, 2015
- Completion date
- Jul 31, 2015
- First posted
- Jan 19, 2015
- Last posted
- Jul 22, 2019
- Enrollment
- 606
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Institute of Tropical Medicine, BelgiumLead sponsor
- Aix-University of MarseilleCollaborator
- Belgian Red CrossCollaborator
- Etablissement Français du SangCollaborator
- Institut National de la Santé Et de la Recherche Médicale, FranceCollaborator
- Government of CongoCollaborator
- University of AntwerpStudy chair
- University of LondonCollaborator
- Medecins Sans FrontieresCollaborator
- University of LiverpoolCollaborator
- University of OxfordCollaborator
- World Health OrganizationCollaborator
- University of AntwerpOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.